@misc{indiciae1d43b4699c7d,
  title = {CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene effect in chronic myeloid leukemia and restores normal hematopoiesis},
  author = {Vuelta, E. and Ordonez, J. L. and Alonso-Perez, V. and Mendez, L. and Hernandez-Carabias, P. and Saldana, R. and Sevilla, J. and Sebastian, E. and Muntion, S. and Sanchez-Guijo, F. and Hernandez-Rivas, J. M. and Garcia-Tunon, I. and Sanchez-Martin, M. A.},
  year = {2020},
  doi = {10.1101/2020.08.05.237610},
  url = {https://www.biorxiv.org/content/10.1101/2020.08.05.237610v1},
  note = {Source identifier: 10.1101/2020.08.05.237610}
}